Mexican regulators gave emergency approval Wednesday to the Chinese-made COVID-19 vaccines CanSino Biologics and CoronaVac.
The approval was announced by deputy health minister Hugo Lopez-Gatell as Mexico struggles to manage the pandemic.
“I have given the authorization for emergency use of both vaccines,” Lopez-Gatell, who serves as the spokesman for the government’s pandemic coordination, said during a press conference.
In addition to CanSino and Sinovac’s CoronaVac, Mexico has authorized three other COVID-19 vaccines: those from Pfizer, AstraZeneca and Russia’s Sputnik V.
In late December, Mexico became the first Latin American country to approve a coronavirus vaccine, followed by Chile and Costa Rica.
So far, only the American-German Pfizer/BioNTech jab has been administered, with health care workers across Mexico and teachers in the southern part of the country having received the jab.
The first shipment of the active ingredient in the British-Swedish AstraZeneca vaccine arrived in Mexico in January, and it is expected to be ready for local use and shipment throughout Latin America by March.
Mexico has officially registered around 170,000 deaths from COVID-19—the world’s third highest toll—and nearly two million known cases.
Follow the latest news on the coronavirus (COVID-19) outbreak
© 2021 AFP
Mexico approves Chinese COVID vaccines CanSino and CoronaVac (2021, February 11)
retrieved 11 February 2021
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no
part may be reproduced without the written permission. The content is provided for information purposes only.
- COVID case rates hit new high for England, study finds - April 7, 2022
- Govt’s focus on affordable healthcare ensured significant savings for poor, middle class: PM Modi - April 7, 2022
- SRL Diagnostics and Skye Air Mobility collaborate to transport pathology samples using drone logistics - April 6, 2022
- Healthineers sets up new production line of CT scanners in Bengaluru under PLI scheme - April 6, 2022
- Lupin inks licensing pact with Alvion to market drugs in Southeast Asia - April 6, 2022
- Yoga Mahotsav: Ayush Ministry to organise event to demonstrate common yoga on World Health Day - April 6, 2022
- LordsMed forays into the medtech space with launch of health ATMs ‘Lords Sehat’ - April 5, 2022
- ‘Friendly viruses’ can be the next big thing in the history of medical research and more - April 5, 2022
- No setback to Bharat Biotech even as WHO suspends Covaxin UN supply: Sources - April 4, 2022
- Govt panel recommends Serum’s Covovax dose for kids aged 12 and above - April 4, 2022